secwatch.observer — SEC 8-K summary
======================================

Issuer:     Yubo International Biotech Ltd (YBGJ)
CIK:        0000895464
Form:       8-K/A
Filed at:   2022-12-07T23:59:59+00:00
Accession:  0001640334-22-002578
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Yubo International amends share agreement to settle $819,229 in loans with World Precision Medicine
--------------------------------------------------------------------------------

- Gross proceeds of $819,229 from 1,638,458 shares at $0.50 will settle all outstanding loan principal and accrued interest.
- Upon delivery, Company has no further repayment obligations and any liens are automatically released.
- Amendment is retroactive to September 2, 2022, executed December 6, 2022, clarifying use of proceeds.
- Shares issued in a registered direct offering under effective S-1 registration statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/895464/000164033422002578/0001640334-22-002578-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/895464/000164033422002578/yubo_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001640334-22-002578

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer